Page 5 - SISK NEWS MARCH 2015 FLIPBOOK. Rev 1_Neat
P. 5
Janssen, leiden in The neTherlands Vital work at the new plant at the Leiden facility will help fight the
Janssen’s is the world’s leading research based Ebola disease.
pharmaceutical company, and part of the Johnson &
Johnson family. The Leiden facility currently produces Practically below sea
Remicade, a drug that treats Crohn’s Disease and level and on a sand
some forms of arthritis. This drug is vital and any threat base, constant dewatering
by disruptive works affecting production is a major
issue for the business and their customers. is imperative.
The project to construct and commission a large This is achieved using
scale vaccine facility within an existing fallow space of sand filters at the water
the live plant started in October 2014. This facility will table and silt separators
produce an Ebola vaccine as its first product. The Sisk
team have a construction management contract for and pumps before
¤25m and commissioning is planned for March 2016. discharge.
Mark Brophy, Sisk’s Senior Contract Manager on the
project, appreciates how vital this facility will be as
he’s worked alongside Johnson & Johnson for many
years. For the process to run smoothly, a number of
initiatives have been put in place to ensure the three
priorities of quality, safety and environmental impact
are monitored.
Monthly ‘Town Hall’ format meetings are held where
the whole site stops for an hour and discusses the
forthcoming works and current issues. Topics include,
amongst others, recent safety audit feedback,
operative awards to promote the highest standards of
work, and environmental audits. When it comes to the
environment, the Janssen team are leading the way.
Over 90% of the Sisk workforce cycle to work!
Machteld Deconinck, Senior Project Manager
for Johnson & Johnson, is keen to promote the
importance of the project in helping the fight against
Ebola, but it is just as important to build safely and
without compromise.
Mark concurs with this view, ‘Janssen appreciate
a project that runs to schedule with the highest
standards, but also one that endorses a safety culture.’
Without the pioneering research companies such as
Janssen undertake, the fight to combat deadly diseases
such as Ebola would be impossible. The Sisk team in
Leiden are incredibly proud to be a part of this fight.
The individual carbon footprint on the Janssen project is incredibly low thanks to 90% of the Constant interaction with
workforce cycling to work. the Leiden Municipality
Inspectors monitors that we
do not over de-water which
would harm flora and fauna
in the local area.
Sisk News | March 2015 5
Janssen’s is the world’s leading research based Ebola disease.
pharmaceutical company, and part of the Johnson &
Johnson family. The Leiden facility currently produces Practically below sea
Remicade, a drug that treats Crohn’s Disease and level and on a sand
some forms of arthritis. This drug is vital and any threat base, constant dewatering
by disruptive works affecting production is a major
issue for the business and their customers. is imperative.
The project to construct and commission a large This is achieved using
scale vaccine facility within an existing fallow space of sand filters at the water
the live plant started in October 2014. This facility will table and silt separators
produce an Ebola vaccine as its first product. The Sisk
team have a construction management contract for and pumps before
¤25m and commissioning is planned for March 2016. discharge.
Mark Brophy, Sisk’s Senior Contract Manager on the
project, appreciates how vital this facility will be as
he’s worked alongside Johnson & Johnson for many
years. For the process to run smoothly, a number of
initiatives have been put in place to ensure the three
priorities of quality, safety and environmental impact
are monitored.
Monthly ‘Town Hall’ format meetings are held where
the whole site stops for an hour and discusses the
forthcoming works and current issues. Topics include,
amongst others, recent safety audit feedback,
operative awards to promote the highest standards of
work, and environmental audits. When it comes to the
environment, the Janssen team are leading the way.
Over 90% of the Sisk workforce cycle to work!
Machteld Deconinck, Senior Project Manager
for Johnson & Johnson, is keen to promote the
importance of the project in helping the fight against
Ebola, but it is just as important to build safely and
without compromise.
Mark concurs with this view, ‘Janssen appreciate
a project that runs to schedule with the highest
standards, but also one that endorses a safety culture.’
Without the pioneering research companies such as
Janssen undertake, the fight to combat deadly diseases
such as Ebola would be impossible. The Sisk team in
Leiden are incredibly proud to be a part of this fight.
The individual carbon footprint on the Janssen project is incredibly low thanks to 90% of the Constant interaction with
workforce cycling to work. the Leiden Municipality
Inspectors monitors that we
do not over de-water which
would harm flora and fauna
in the local area.
Sisk News | March 2015 5
